Dr. Capitanio Discusses Adjuvant Therapy for High-Risk Kidney Cancer
November 19th 2017
Umberto Capitanio, MD, FEBU, department of Urology, San Raffaele Scientific Institute, University Vita-Salute San Raffaele, discusses adjuvant therapy for patients with high-risk kidney cancer without metastases.